A Phase II Trial of Autologous Stem Cell Transplantation Followed by Mini-Allogeneic Stem Cell Transplantation for the Treatment of Multiple Myeloma: An Analysis of Eastern Cooperative Oncology Group ECOG E4A98 and E1A97-Reference-Cited by-同舟云学术

A Phase II Trial of Autologous Stem Cell Transplantation Followed by Mini-Allogeneic Stem Cell Transplantation for the Treatment of Multiple Myeloma: An Analysis of Eastern Cooperative Oncology Group ECOG E4A98 and E1A97

Published:2009-01 Issue:1 Volume:15 Page:83-91
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Vesole David H.,Zhang Lijun,Flomenberg Neal,Greipp Philip R.,Lazarus Hillard M.

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference32 articles.

1. Standard chemotherapy compared with high-dose chemoradiotherapy for multiple myeloma: final results of phase III US Intergroup Trial S9321;Barlogie;J Clin Oncol,2006

2. Allogeneic marrow transplantation for multiple myeloma: an analysis of risk factors on outcome;Bensinger;Blood,1996

3. Reduced-intensity conditioning for myeloma: lower nonrelapse mortality but higher relapse rates compared with myeloablative conditioning;Crawley;Blood,2007

4. Progress in allogeneic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983-93 and 1994-98 at European Group for Blood and Marrow Transplantation centres;Gahrton;Br J Haematol,2001

5. Improved outcome of allogeneic transplantation in high-risk multiple myeloma patients after nonmyeloablative conditioning;Badros;J Clin Oncol,2002

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of timing of stem cell return following high dose melphalan in multiple myeloma patients with renal impairment: a single center experience;Leukemia & Lymphoma;2023-06-01

2. Allogeneic Transplantation in Multiple Myeloma—Does It Still Have a Place?;Journal of Clinical Medicine;2020-07-10

3. The effects of cold atmospheric plasma on cell adhesion, differentiation, migration, apoptosis and drug sensitivity of multiple myeloma;Biochemical and Biophysical Research Communications;2016-05

4. CD34-Selected Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Relapsed, High-Risk Multiple Myeloma;Biology of Blood and Marrow Transplantation;2016-02

5. A myeloma multiplex megközelítése Magyarországon 2016-ban;Orvosi Hetilap;2016-01